91心頭

+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

Insulin Pen Market - Product Thumbnail Image

Insulin Pen Market

  • Report
  • February 2024
  • 78 Pages
  • Global
From
From
From
Insulin Pens Market - Global Outlook & Forecast 2022-2027 - Product Thumbnail Image

Insulin Pens Market - Global Outlook & Forecast 2022-2027

  • Report
  • March 2022
  • 260 Pages
  • Global
From
Diabetic nephropathy Market - Global Forecast 2026-2032 - Product Thumbnail Image

Diabetic nephropathy Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 186 Pages
  • Global
From
Insulin Delivery Devices Market - Global Forecast 2026-2032 - Product Thumbnail Image

Insulin Delivery Devices Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 187 Pages
  • Global
From
From
From
From
From
Insulin Delivery Pens Market - Global Forecast 2026-2032 - Product Thumbnail Image

Insulin Delivery Pens Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 182 Pages
  • Global
From
From
Ibuprofen Arginine API Market - Global Forecast 2026-2032 - Product Thumbnail Image

Ibuprofen Arginine API Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 199 Pages
  • Global
From
From
Insulin Detemir Injection Market - Global Forecast 2026-2032 - Product Thumbnail Image

Insulin Detemir Injection Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 187 Pages
  • Global
From
From
Loading Indicator